Cargando…

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times

Detalles Bibliográficos
Autores principales:	Singh, Awadhesh K, Singh, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544089/ https://www.ncbi.nlm.nih.gov/pubmed/34427273 http://dx.doi.org/10.4103/ijo.IJO_1423_21

Ejemplares similares

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Role of Face Masks in the Rise of Mucormycosis Cases in India during the COVID-19 Pandemic
por: Chandan, SN
Publicado: (2021)

Comment to: “Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2022)

Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021)

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

COVID 19 infection and mucormycosis—a dangerously increasing combination
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope
por: Jadaun, Shekhar Singh, et al.
Publicado: (2021)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Fungal phoenix rising from the ashes?
por: Wingfield, Michael J., et al.
Publicado: (2010)

Mathematical Modeling of the Phoenix Rising Pathway
por: Liu, Chad, et al.
Publicado: (2014)

COVID-19 and the Lebanese Crisis: Will the Phoenix Manage to Rise Once Again?
por: Bizri, Abdul Rahman, et al.
Publicado: (2020)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

The postpartum oto-rhino- cerebral mucormycosis - A case study
por: Singh, Ranju, et al.
Publicado: (2023)

Comment to: Teleconsultation of infant rheumatology in COVID-19 time
por: Qanneta, Rami
Publicado: (2023)

ESTSS at 20 years: “a phoenix gently rising from a lava flow of European trauma”
por: Ørner, Roderick J.
Publicado: (2013)

Psychiatry in Cambodia: the phoenix rises from the ashes
por: MacCabe, James, et al.
Publicado: (2007)

A toddler infected with mucormycosis – reporting the youngest case of mucormycosis in post COVID phase
por: Kubre, Jyotsna, et al.
Publicado: (2023)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023)

Why is COVID-19 rising in summer?
por: Kulkarni, Raghavendra D.
Publicado: (2021)

Rising Incidence of Post Covid Rhinocerebral Mucormycosis: An Otolaryngologists Prospective
por: Sahni, Dimple, et al.
Publicado: (2023)

Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?
por: Kumar, Amarjeet, et al.
Publicado: (2022)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3d6get7fjripegj67h2079lf4